AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE and CARDIAC FAILURE CONGESTIVE

Overview

CARDIAC FAILURE CONGESTIVE is the #14 most commonly reported adverse reaction for AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE, manufactured by Novartis Pharmaceuticals Corporation. There are 305 FDA adverse event reports linking AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE to CARDIAC FAILURE CONGESTIVE. This represents approximately 1.6% of all 18,930 adverse event reports for this drug.

Patients taking AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE who experience cardiac failure congestive should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

CARDIAC FAILURE CONGESTIVE is a less commonly reported adverse event for AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE, but still significant enough to appear in the safety profile.

Other Side Effects of AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE

In addition to cardiac failure congestive, the following adverse reactions have been reported for AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE:

• NAUSEA — 620 reports
• FATIGUE — 532 reports
• DRUG INEFFECTIVE — 525 reports
• DIZZINESS — 478 reports
• DIARRHOEA — 452 reports
• DYSPNOEA — 426 reports
• HEADACHE — 414 reports
• PAIN — 400 reports
• ASTHENIA — 385 reports
• MYOCARDIAL INFARCTION — 352 reports

Other Drugs Associated with CARDIAC FAILURE CONGESTIVE

The following drugs have also been linked to cardiac failure congestive in FDA adverse event reports:

Does AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE cause CARDIAC FAILURE CONGESTIVE?

CARDIAC FAILURE CONGESTIVE has been reported as an adverse event in 305 FDA reports for AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is CARDIAC FAILURE CONGESTIVE with AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE?

CARDIAC FAILURE CONGESTIVE accounts for approximately 1.6% of all adverse event reports for AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE, making it a notable side effect.

What should I do if I experience CARDIAC FAILURE CONGESTIVE while taking AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE?

If you experience cardiac failure congestive while taking AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages